Published: 21 October 2023
Author(s): Samuel J. Martínez-Domínguez, Sandra García-Mateo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Engy Refaie, Pilar Callau, Carolina Mendi, Pedro M. Baptista, María Hernández Ainsa, María Teresa Arroyo-Villarino, Julia López de la Cruz, Javier Martínez-García, Erika Alfambra, Miguel Ángel Simón Marco, Javier Ampuero, Fernando Gomollón
Issue: March 2024
Section: Original article

Inflammatory Bowel Diseases (IBD) are chronic inflammatory pathologies that mainly affect gastrointestinal tract, including Crohn´s Disease (CD), Ulcerative Colitis (UC) and Indeterminate Colitis (IC). The incidence of IBD is progressively increasing at the same time that new therapeutic targets are emerging in recent decades [1,2]. Lifestyle and the improved control of inflammatory activity have probably contributed to a new trend in the nutritional status of IBD patients [3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.